Tag: post-market surveillance

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

The FDA doesn't stop monitoring generic drugs after approval. Using real-time data, patient reports, and AI tools, it tracks safety across millions of prescriptions. Here's how the system works-and how you can help.